Reported Deaths Linked to GLP-1RA Receptor Agonist Drugs: Ozempic, Mounjaro, & Wegovy
Emerging Safety Concerns and Mortality Data from Weight Loss and Diabetes Medications Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as Mounjaro (tirzepatide), Wegovy and Ozempic (semaglutide), and Saxenda (liraglutide) have surged in popularity for both type 2 diabetes management and weight